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ABSTRACT 
DEVELOPMENTAL EFFECTS OF NICOTINE IN DROSOPHILA MELANOGASTER 
By Lisa Wong 
Approximately 12%-20% of pregnant women smoke at some point during pregnancy, 
and 10% of pregnant women are reported to have smoked during the last 3 months of 
pregnancy. Smoking during pregnancy leads to developmental health risks for the fetus 
and child, including increased mortality, low birth weight, and developmental delays. The 
direct molecular targets of nicotine are nicotinic acetylcholine receptors (nAChRs) due to 
the similarities in structure between nicotine and acetylcholine. However, in many cases, 
it remains unclear what molecular events downstream of nAChRs lead to the deleterious 
effects of nicotine on development. We have established Drosophila melanogaster as a 
genetic model system to study the developmental effects of nicotine. So far, we have 
established that nicotine reduces survival and increases development time in a dose-
responsive manner. In addition, we have evidence that developmental nicotine exposure 
may reduce adult body weight, and that ethanol and nicotine act in a non-additive fashion 
to reduce survival. Finally, we show that nicotine exposure does not appear to affect brain 
size in developing larvae. Our results show that the effects of nicotine on fly development 
are similar to those seen in mammals, and establish Drosophila as a model organism for 
the study of the deleterious effects of nicotine on development. 
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Introduction 
Developmental Nicotine Exposure 
Cigarettes contain thousands of harmful chemicals, and smoking causes many 
adverse health outcomes. Chief among these chemicals is nicotine, which is found 
naturally in tobacco and is very highly addictive (American Heart Association [AHA], 
2015). Some of the risks associated with smoking are heart disease, stroke, and lung 
cancer (CDC, 2017). Although smoking is well-known to cause serious health risks, 
15.1% of all adults still smoke (CDC, 2017). Even though smoking by pregnant women 
leads to additional health risks to the unborn child, there is a higher prevalence for 
maternal smoking in women aged 20-24 (13.0%) than other age groups and the highest 
rate is for American Indian or Alaska Native women (18.0%) (Curtin & Mathews, 2016). 
This prevalence of smoking is likely at least in part due to the highly addictive nature of 
nicotine (CDC, 2017).  
Nicotine affects the mesolimbic pathway (also known as the reward pathway). Upon 
stimulation, this neural circuit releases the neurotransmitter dopamine, which is 
responsible for the pleasurable feelings associated with rewards (Adinoff, 2004). The 
mesolimbic pathway plays a role in reward behaviors and simple motor responses (Figure 
1). Rewarding behaviors (e.g. sex, eating, or smoking) increase dopamine levels, leading 
to reinforcement of the behavior. Similarly, most drugs of abuse also stimulate the 
mesolimbic pathway to release dopamine (Blum et al., 2012). 
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Figure 1. Mesolimbic Pathway Diagram. Smoking releases dopamine from the 
mesolimbic pathway, which regulates motivation and desire. 
 
Nicotine and Nicotinic Acetylcholine Receptors (nAChRs). Tobacco plants are 
grown for their leaves, which are dried and fermented before being put in cigarettes 
(National Institute on Drug Abuse, 2017). When a person decides to smoke a cigarette, he 
or she is being exposed to smoke containing nicotine in small particles that are rapidly 
absorbed through the lungs and into the bloodstream. Finally, nicotine is lipid soluble, 
which allows it to freely cross the blood brain barrier (Riah et al., 1998). 
Once inside the brain, nicotine binds to nicotinic acetylcholine receptors (nAChRs). 
The endogenous ligand for nAChRs is acetylcholine, a neurotransmitter involved in 
(among other functions) muscle movement, learning, memory, and heart rate (Kihara & 
Shimohama, 2004). Nicotine has a structure similar to that of acetylcholine and so will 
Mesolimbic pathway 
Nucleus accumbens 
Substantia nigra 
Ventral tegmented area 
Spinal cord 
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bind and activate nAChRs (Xiu et al., 2009). When the body is bombarded with nicotine 
from smoking, these receptors are activated in the absence of acetylcholine, activating a 
variety of downstream signal transduction cascades. Because of the variety of nAChRs 
subtypes expressed in the brain, little is known about the specific downstream molecular 
and cellular events leading to the deleterious effects of developmental nicotine exposure.  
Physiological Effects of Nicotine on Growth and Development 
One adverse outcome of smoking during pregnancy is an increase in developmental 
mortality, which expresses itself in a variety of ways, including miscarriages, premature 
births which lead to a decrease in survival, and sudden infant death syndrome (SIDS). 
SIDS is defined as the sudden and unexplained death of an infant that is less than one 
year old. The children of women who smoked during pregnancy are at three times the 
normal risk of SIDS (Wisborg et al., 2000). Maternal smoking is a factor in up to 21% of 
all SIDS cases (Shah et al., 2006). Smoking or other tobacco use is a risk factor that 
contributes to adverse outcomes like premature births.  One out of ten premature births in 
the United States in 2015 is due to maternal smoking (CDC, 2017). There is a strong dose 
response association with smoking and the increased risk of miscarriages (Mishra et al., 
2000). 
Nicotine Causes Reduced Brain Growth and Neurodevelopmental Abnormality.  
Smoking during the second trimester of pregnancy affects the brain and is associated 
with reduced brain growth (Chatterton et al., 2017).  In a previous in vivo study, it was 
found that nicotine exposed human fetal cortical plates contained fewer neurons than 
unexposed cortical plates, as defined by staining for Ki67, a marker for cellular 
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proliferation. This region normally has numerous cortical layers, but developmental 
nicotine exposure is associated with reductions in both numbers and neurons and cortical 
layers, but developmental nicotine exposure is associated with a reduction in neuronal 
content. Cigarettes contain thousands of chemicals, which makes it difficult to link 
compounds to specific phenotypes. 
Further, it has been proposed that the exposure to nicotine due to smoking 
dysregulates the dopaminergic system and the nicotinic acetycholinergic circuits in the 
brain (Mcclernon & Kollins, 2008), an effect that appears to be connected to an increased 
incidence of attention deficit hyperactivity disorder (ADHD) (Mcclernon & Kollins, 
2008). ADHD is characterized by inattention, hyperactivity, and impulsivity (Rosenthal 
et al., 2011). Smoking during pregnancy is one of the most significant risk factors for a 
diagnosis of ADHD (Rosenthal et al., 2011), and comorbidity of maternal prenatal 
smoking and ADHD is common and significantly more than predicted by chance, 
although the mechanisms by which prenatal smoking leads to ADHD are unknown 
(Mcclernon & Kollins, 2008). 
Growth Deficiencies Associated with Smoking. Maternal smoking during 
pregnancy has been consistently linked to low birth weight in infants, especially when 
exposure occurs in the third trimester of pregnancy. Increased smoking during the third 
trimester has been shown to reduce birth weight (Bernstein et al., 2005). This aligns with 
many previous studies suggesting an increase in maternal smoking is associated with low 
birth weight (Pereira et al., 2017) 
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Craniofacial Abnormalities and Developmental Nicotine Exposure. In addition to 
the conditions described in previous sections, there is an association between smoking 
and craniofacial abnormalities. Cleft palate is an example; it is a condition in which there 
is an opening of the lip, which can extend into the nose (Figure 2). This craniofacial 
abnormality is one of the effects of prenatal smoking in women (Honein et al., 2017). 
There is a significant dose response trend that suggests maternal smoking and having a 
child with cleft palate are directly linked (Chung et al., 2000). 
 
Figure 2. Cartoon of an infant with cleft lip/palate. Cleft palate is a craniofacial 
abnormality resultig from defects in midline closure during early development, and can 
be caused by developmental exposure to nicotine. (This image courtesy of Centers for 
Disease Control and Prevention, National Center on Birth Defects and Developmental 
Disabilities). 
 
Nicotine and Ethanol are Often Comorbid 
Maternal smoking alone carries health risks to the developing fetus, but when 
nicotine is co-abused with alcohol, the risk significantly increases. The combination of 
prenatal smoking and drinking is associated with an increased risk of mortality (Beeker et 
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al., 1992), SIDS (Fifer et al., 2009), and developmental delay (Polańska et al., 2015), but 
whether these increases are due to additive effects of the two drugs, or, alternatively, 
because the drugs have overlapping targets, is not known.   
Drosophila Melanogaster as a Model for Development 
D. melanogaster has been widely used in studies to model the effects of drugs of 
abuse, including alcohol, cocaine, and nicotine (Kaun et al., 2012), as well as the effects 
of developmental exposure to the same addictive drugs (Logan-Garbisch et al., 2014; 
McClure, French, & Hebelein, 2011). In addition, the molecular pathways of 
development are conserved between flies and humans.  
Finally, Drosophila are ideal for developmental studies for a number of reasons. Flies 
have a short life cycle (approximately two weeks), and are inexpensive and easy to 
culture. For over 100 years, flies have been used to study basic cellular processes as well 
as complex behaviors, including but not limited to:  basic developmental pathways 
(Arias, 2008), learning and memory processes (Gong et al., 1998), sleep (Shaw et al., 
2000), and the physiological and behavioral response to drugs of abuse, including alcohol 
(Wolf & Heberlein, 2003). 
This thesis will focus on the effects of nicotine on development in wild-type D. 
melanogaster, as well as interactions between nicotine and ethanol. We show that 
nicotine has a dose-responsive effect on both survival and development time, and that 
nicotine exposure may reduce adult fly body weight. In addition, we show that ethanol 
and nicotine have synergistic effects on developmental mortality, suggesting common 
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downstream targets within the cell. Finally, we show that developmental nicotine 
exposure does not alter larval brain size. 
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Materials & Methods 
Fly Stocks 
The strain used for all experiments was our standard lab background strain [w1118; 
Wild Type Berlin (w;WTB). Fly stocks were maintained at 25 oC on a standard 
cornmeal/molasses medium unless otherwise stated. 
Fly Food Recipes
• 0.01% Nicotine Food:  28.57 uL 35% w/v Nicotine were added to 99.91 mL of 
standard cornmeal/molasses medium. 
• 0.02% Nicotine Food:  57.14 uL 35% w/v Nicotine were added to 99.94 mL of 
standard cornmeal/molasses medium. 
• 0.03% Nicotine Food:  85.71 uL 35% w/v Nicotine were added to 99.91 mL of 
standard cornmeal/molasses medium. 
• 5% EtOH Food:  2.5mL EtOH were added to 47.5 mL standard 
cornmeal/molasses medium. 
• 0.01% Nicotine and 5% EtOH Food:  28.57 uL 35% w/v Nicotine and 5 mL 
EtOH were added to 94.97 mL of standard cornmeal/molasses medium.
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Developmental Nicotine Exposure  
Flies were transferred to egg laying bottles topped with petri dishes containing 
standard fly food. Egg collections were taken for 16-24 hours. A hundred eggs (N=4) 
were then transferred to vials containing either control food, nicotine-containing food 
(0.01%, 0.02%, or 0.03% nicotine final concentrations), 5% ethanol-containing food, or 
food containing both nicotine and ethanol, and, for ethanol exposure experiments, placed 
in a experimental condition of 5% ethanol bath (Figure 3). The ethanol bath ensures that 
developing animals are exposed to ethanol during their entire development, which 
continues for another 10 to 16 days. After eclosion, the newly hatched adult flies were 
counted daily at the same time for the duration of the experiment (between 9 and 20 
additional days). The data were used to generate cumulative eclosion rate plots, a direct 
measurement of egg-to-adult survival, and the time to 50% of total eclosion. Time to 50% 
eclosion was calculated by linear interpolation. 
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Figure 3. Developmental nicotine exposure assay diagram.   
(A)  Standard fly food is used in food plates. (B) Flies are placed in egg laying bottles to 
mate and lay eggs on food plate. (C) After 24 hours new food plates are used and 100 
eggs are transferred into vials (D) containing either control or experimental food, and 
incubated in water or ethanol baths at 25°C for the duration of the experiment (E).   
 
Weight 
Flies were reared on control (0%) and experimental food (0.01%, 0.02%, or 0.03% 
nicotine). Upon eclosion, 100 female flies from each condition were collected and 
weighed. Average weight per fly was calculated by dividing the total weight for that 
condition (in mg) by 100. 
 
 
A B C 
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Immunostaining and Imaging 
Brains were dissected and fixed according to Wu and Luo (2006) with the following 
modifications: tissues were fixed for 1 hour, incubated with Normal goat serum (NGS) 
block for 24 hours. Brains were then incubated in NC82 primary antibody in block for 4 
days followed by two days in secondary antibody. NC82 mouse anti-Brp was used at 
1:50 (Developmental Studies Hybridoma Bank, AB 2314866). Secondary antibody Alexa 
Fluor 594 goat anti-mouse was used at 1:1000 (Jackson Immunoresearch, 705-586-147). 
Images were taken using a Zeiss LSM700 confocal microscope. A level of 0.05% was 
used in all experiments.  Data are represented as mean ± s.e.m. Data were analyzed using 
one-way analysis of variance (ANOVA), followed by Tukey’s HSD post hoc test.  No 
statistical tests were used to predetermine sample sizes, but our sample sizes are 
consistent with those reported in previous publications (McClure et al., 2010; Luu et al., 
2016; Tran el al., 2014). 
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Results 
Nicotine Exposure During Development Causes a Dose-Dependent Increase in 
Mortality and Development Time 
 
Larvae were reared on a diet of standard fly food (see Materials and Methods) 
containing nicotine at a concentration of 0.01%, 0.02%, or 0.03% (experimental 
conditions) or food containing 0% nicotine (control conditions). Survival and 
development times were assayed starting 10 days after egg-laying by daily counts of 
eclosed adult flies. Nicotine at a concentration of 0.01% had no significant effect on 
survival, with a median survival on control food of 79.25% and 76.5% on food 
containing 0.01% nicotine (Figure 4). However, when we increased the nicotine 
concentration to 0.02%, median survival dropped to 41%, a significant reduction 
compared with controls (p < 0.0001, one-way ANOVA with Tukey post-hoc analysis, 
n=4). This trend continued when the nicotine concentration was increased to 0.03%. At 
this concentration, only 7% of flies survived to eclosion (p < 0.0001, one-way ANOVA 
with Tukey post-hoc analysis, n=4). These data demonstrate that nicotine exposure 
during development causes a dose-dependent decrease in survival in Drosophila. 
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Figure 4.  Nicotine causes a dose responsive reduction in survival? One hundred eggs 
were transferred to each vial containing 0% nicotine food as the control and 0.01%, 
0.02%, and 0.03% nicotine food.  The percent survival was assessed daily and data 
organized into a scatterplot.  * denotes p<0.0001, differing from all other means.  
Horizontal bars represent mean. N=4 for all conditions, p<0.0001 one way ANOVA with 
Tukey’s HSD post-hoc analysis. 
 
 In addition to its effects on survival, developmental nicotine exposure caused a 
developmental delay (Figure 5). In control animals, time to 50% eclosion was 10.46 days. 
While 0.01% nicotine had no effect on survival, it did result in a small but significant 
delay, with animals reared in 0.01% nicotine having a time to median eclosion of 11.29 
days. As the concentration of nicotine was increased, time to median eclosion also 
increased: flies reared in 0.02% nicotine showed a 2.16 day delay (p<0.0001, one-way 
ANOVA with Tukey post-hoc analysis, n=4), while flies reared in 0.03% nicotine a 3.00 
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day delay when compared to control (p<0.0001, one way ANOVA with Tukey post-hoc 
analysis, n=4). These data are summarized in Table 1. These data demonstrate that 
nicotine exposure during development results in a significant developmental delay.
 
Figure 5. Developmental nicotine exposure causes developmental delay.  0% as 
the control and nicotine concentrations of 0.01%, 0.02%, and 0.03% were 
assessed.  Data have been normalized to the total number of flies eclosed for each 
condition. Upon eclosion comparisons for time to 50% eclosion were assessed. 
(p<0.05, one way ANOVA with Tukey’s HSD post-hoc analysis, n=4. 
 
Table 1. Nicotine Causes a Dose-Responsive Delay in Development Time 
 
Note. Survival assay comparing developmental delay from nicotine-reared larvae with 
control larvae. Nicotine-reared wild-type larva showed a developmental delay as 
concentration increases.  
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Nicotine Exposure During Development May Decrease Adult Body Weight 
For each experimental condition (0%,  0.01%, 0.02%, and 0.03% nicotine), we 
collected and weighed 100 adult female flies upon eclosion. The average weight of 
control flies was 1.23 mg. Flies reared on 0.01% nicotine weighed 1.16 mg on average, a 
5% decrease in weight when compared with controls. Finally, 0.02% and 0.03% nicotine 
each resulted in a 13% decrease in body weight (average body weight 1.06 mg) (Figure 
6). These data suggest that nicotine exposure during development may have an effect on 
adult body weight. As this experiment has not been repeated, we have not performed 
statistical analysis of our body weight data. We are continuing to examine the effects of 
nicotine on adult body weight. 
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Figure 6. Developmental nicotine exposure may reduce adult body weight. Flies reared 
on 0.01% nicotine show a 5% reduction in adult weight, while both 0.02% & 0.03% 
nicotine result in a 13% reduction in adult weight.   
 
Nicotine and Ethanol Have a Synergistic Effect on Survival 
In cases of prenatal nicotine exposure in humans, simultaneous exposure to alcohol is 
common (McMurray et al., 2008). In addition, nicotine and ethanol cause similar effects 
on growth and development (McClure et al., 2011). We therefore exposed flies to a 
combination of nicotine and ethanol in order to ask whether the effects of the two drugs 
are synergistic, which would suggest overlapping molecular targets. 
Larvae were reared on 0.01% nicotine, 5% ethanol, and a combination of 0.01% 
nicotine and 5% ethanol. These concentrations of nicotine (0.01%) and ethanol (5%) have 
minimal to no effect on growth and development, making it easier to detect possible 
synergistic effects. The results of these experiments are presented in Figure 7. Nicotine at 
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a concentration of 0.01% had no significant effect on survival, as seen previously (Figure 
4). 5% ethanol had a significant negative effect on survival, but the combination of 
0.01% nicotine and 5% ethanol resulted in a significant synergistic effect (Figure 7), 
which suggests that these drugs have common downstream targets.  
 
Figure 7.  Nicotine and ethanol have synergistic effects on developmental mortality. One 
hundred eggs were transferred to each vial containing 0% nicotine food as the control, 
0.01% nicotine food, 5% ethanol food, and a combination of 0.01% nicotine and 5% 
ethanol food.  The percent survival assessed daily and data organized into a scatterplot.  * 
= p<0.0001.  Horizontal bars represent mean  N=4 for all conditions, p<0.0001 two way 
ANOVA with Tukey’s HSD post-hoc analysis. 
 
Nicotine and Ethanol Exposure During Development Cause a Synergistic Increase 
in Development Time 
 
Larvae were reared on 0.01% nicotine, 5% ethanol, and a combination of 0.01% 
nicotine and 5% ethanol as described in Section 3.1, and developmental delay was 
assayed by daily counts of the larva as they eclosed into adult flies as described in 
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Section 3.1.  Larvae reared in 0.01% nicotine showed a 0.56 day delay compared with 
control flies, while rearing in 5% ethanol resulted in a 1.07 day delay when compared to 
control. When the two drugs were combined, the delay increased to 2.08 days as 
compared to control (Figure 8 and Table 2), and this effect is greater than the predicted 
effect of a simple combination of the two individual effects (p= 0.024, two-way ANOVA 
with Tukey post-hoc analysis, n=4). The combination of these two drugs, ethanol and 
nicotine, causes a synergistic increase in development time. 
 
 
Figure 8.  Nicotine and ethanol have synergistic effects on developmental mortality. 
Vials containing 0% nicotine food as the control, 0.01% nicotine food, 5% ethanol food, 
and a combination of 0.01% nicotine and 5% ethanol food were assessed.  Data were 
normalized to the total number of flies eclosed for each condition.  Upon eclosion 
comparisons for time to 50% eclosion were assessed. (p=0.024, two way ANOVA with 
Tukey’s HSD post-hoc analysis, n=4). 
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Table 2. Time to Median Eclosion For Flies Reared in Both Ethanol and Nicotine  
 
Note. Survival assay comparing developmental delay from nicotine-reared larvae with 
control larvae. Nicotine-reared wild-type larva showed a developmental delay as 
concentration increases. 
 
The Combination of Nicotine and Ethanol Exposure During Development Does Not 
Affect Adult Weight 
 
Larvae were reared on 0.01% nicotine, 5% ethanol, and a combination of 0.01% 
nicotine and 5% ethanol. We collected and weighed 100 adult female flies upon eclosion, 
and found that the average weight for all conditions was similar (Figure 9; p> 0.05, two 
way ANOVA with Tukey post-hoc analysis, n=4).  Flies reared on 0.01% nicotine, 5% 
ethanol, and a combination of both drugs show no difference in adult weights, indicating 
that, at these concentrations, there is no synergistic effect of ethanol and nicotine on 
reduction of adult body weight. Thus, low concentrations of nicotine and ethanol do not 
affect adult body size in Drosophila. 
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Figure 9. Nicotine and ethanol do not synergize to alter adult body weight. There is no 
synergistic effect of ethanol and nicotine on reduction of adult body weight (p > 0.05, 
two way ANOVA with Tukey’s post-hoc analysis, n=4). 
  
Nicotine Exposure During Development Does Not Affect Larval Brain Size 
Developmental exposure to nicotine in animal models has indicated changes in 
neuronal cell replication and differentiation. When pregnant rats were exposed 
comparable nicotine levels to those experienced by human smokers there was a 
substantial reduction in cell number in the resulting pups, demonstrating that prenatal 
nicotine exposure compromised brain development (Roy et al., 2002). We therefore 
asked whether developmental nicotine exposure elicits reductions in brain size in 
Drosophila. 
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Larvae were reared on 0% (control conditions) or 0.02% nicotine (experimental 
conditions). Brains were dissected from wandering 3rd instar larva and stained with 
monoclonal antibody NC82. NC82 recognizes the protein Bruschilot, which labels the 
presynaptic active zone of all neurons and is the standard marker for labeling neuropil in 
fly brains (Figure 10). We used Image J to analyze confocal reconstructions of control 
(Figure 10A, n=14) and nicotine-exposed (Figure 10B, n=25) brains, measuring the inter-
optic-lobe brain diameter. We found that brain sizes were similar in both conditions (see 
Figures 10C and D), indicating that exposure to 0.02% nicotine during larval 
development has no effect on brain size (p > 0.05, Student’s T-test).   
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Figure 10. Developmental nicotine exposure does not alter larval brain size.  A and B:   
Confocal micrographs of NC82-stained brains dissected from a 3rd instar control larva 
(A) and a 3rd instar larva after rearing in 0.02% nicotine (B). C. Brain size, as measured 
by inter-optic-lobe distance.  
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Discussion 
Developmental nicotine exposure causes a wide range of adverse health risks 
including increased mortality, developmental delay, growth deficiencies, craniofacial 
abnormalities, and neurobehavioral deficits. Nicotine acts as an agonist for nAChRs, but 
the molecular events downstream of the nAChRs that lead to the deleterious 
developmental effects of nicotine are largely uncharacterized. We have established 
Drosophila melanogaster as a model for developmental nicotine exposure in order to 
begin identifying the molecular targets of nicotine exposure. We show here that larval 
nicotine exposure in Drosophila causes decreased survival, developmental delay, and 
reduced adult weight. In addition, we show a synergistic effect of ethanol and nicotine 
during development, suggesting that nicotine and ethanol have overlapping cellular 
targets. 
Nicotine Exposure Causes Developmental Mortality and Developmental Delays 
When exposed to nicotine during larval development, wild type flies displayed a 
dose-dependent increase in developmental mortality (Figure 4) and delayed time to 
median eclosion (Figure 5 and Table1). This result is similar to the effects of cigarette 
smoking on fetal development as seen in previous studies, which causes an increase in 
both prenatal and perinatal death: smoking during pregnancy is associated with an 
increased risk of miscarriage and stillbirth (Hofhuis, 2003). In addition, 21% of all cases 
of SIDS cases are associated with smoking during pregnancy (Shah et al., 2006). As 
shown with other studies a number of neurological delays are associated with prenatal 
nicotine exposure, including attention deficit hyperactivity disorder (ADHD) (Langley et 
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al., 2011). ADHD is a syndrome characterized by trouble paying attention, impulsive 
behaviors indicating insufficient executive function, and hyperactivity (National Institute 
of Mental Health, 2016).  
Growth Deficiencies 
Our study suggests that, at higher concentrations (0.02% or 0.03%) developmental 
nicotine exposure may lead to a decrease in adult weight. This is consistent with the 
literature on prenatal smoking. Prenatal nicotine exposure leads to growth deficiencies, 
and low birth weight is the primary fetal risk associated with smoking during pregnancy. 
As the amount of maternal smoking increases, there is a concomitant decrease in birth 
weight (Secker-Walker & Vacek, 2003).  
Brain Size 
This study did not show a significant effect on brain size due to developmental 
nicotine. This is not consistent with other studies that associate maternal smoking with 
reduced fetal brain growth. Maternal smoking impacts brain development and is 
associated with reduced fetal brain growth (Chatterton et al., 2017).  It is possible that the 
dose of nicotine used here are not high enough to elicit large-scale effects on brain 
development; alternatively, this may be an area in which insect development differs from 
mammalian development. It is also possible that the effects of smoking on brain growth 
are not due to nicotine, but rather to another of the many harmful chemicals found in 
tobacco smoke. In future, we plan to address the question of the effects of nicotine on 
brain development in flies in two ways: first, by using higher doses of nicotine, and, 
	 25	
second, by examining the effects of nicotine on the development of specific brain 
structures, such as the mushroom bodies.  
Future Directions 
In the future, there are several questions that we would like to address. First, what is 
the critical period of development for the various phenotypes described in this thesis? 
This can be addressed by transferring developing larvae to nicotine-containing food at 
various developmental stages and assessing the effects on survival and growth. The 
importance of knowing the critical stage of development affected by developmental 
nicotine exposure will help to reduce the adverse health risks associated with 
maternal smoking. 
In addition, as indicated above, we intend to pursue the question of nicotine’s effect 
on brain development in two ways: by measuring brain sizes in animals exposed to higher 
concentrations of developmental nicotine, and by examining specific regions of the 
developing brain for changes in nicotine-exposed animals. Of particular interest are the 
mushroom bodies, the fly analog of the hippocampus, as the hippocampus is particularly 
sensitive to nicotine exposure in mammals (Gallinat et al., 2007).  In addition, the 
hippocampus is affected in neurodegenerative disorders including Alzheimer Disease. A 
better understanding of the effects of nicotine on the development of these regions may 
result in greater understanding of the underlying mechanisms of Alzheimer Disease, and, 
ultimately, the development of therapies (Regensburger et al., 2014). 
Finally, our data indicate a synergistic effect of nicotine and ethanol, suggesting that 
these drugs have overlapping downstream targets. We will begin identifying the common 
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targets by testing mutants that are known to be resistant or sensitive to the developmental 
effects of ethanol for similar alterations when reared in food containing nicotine.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 27	
References 
 
Adinoff, B. (2004). Neurobiologic Processes in Drug Reward and Addiction. Harvard 
Review of Psychiatry, 12(6), 305–320. doi:10.1080/10673220490910844 
 
 
American Heart Association [AHA]. (2015). Why is it so hard to quit? Retrieved from 
http://www.heart.org/HEARTORG/HealthyLiving/QuitSmoking/YourNon-
SmokingLife/Why-is-it-so-hard-to-
quit_UCM_324053_Article.jsp#.WVPvKcaZPUo 
 
 
Arias, A. M. (2008). Drosophila melanogaster and the development of biology in the 20th 
century. Methods in Molecular Biology, 420, 1–25. doi:10.1007/978-1-59745-583-
1_1 
 
 
Beeker, K., Smith, C., & Pennington, S. (1992). Effect of cocaine, ethanol or nicotine on 
ornithine decarboxylase activity in early chick embryo brain. Brain Research 
Developmental Brain Research, 18;69(1), 51–7. Retrieved from 
https://www.ncbi.nlm.nih.gov/pubmed/1424089 
 
 
Bernstein, Ira M., Mongeon, Joan A., Badger, Gary J., Solomon, Laura, Heil, Sarah, and 
Higgins, S. (2005). Maternal Smoking and Its Association With Birth Weight Ira. 
Obstetrics and Gynecology, 106(5 part 1), 986–991. 
 
 
Blum, K., Werner, T., Carnes, S., Carnes, P., Bowirrat, A., Giordano, J., … Gold. (2012). 
Sex, Drugs, and Rock “N” Roll: Hypothesizing Common Mesolimbic Activation as 
a Function of Reward Gene Polymorphisms. Journal of Psychoactive Drugs, 44(1), 
38–55. doi:10.1080/02791072.2012.662112 
 
 
Center for Disaese Control and Prevention [CDC]. (2017). Quitting Smoking. Retrieved 
from 
 https://www.cdc.gov/tobacco/data_statistics/fact_sheets/cessation/quitting/index.htm 
 
 
Centers for Disease Control [CDC]. (2017). Preterm Birth. Retrieved from 
https://www.cdc.gov/reproductivehealth/maternalinfanthealth/pretermbirth.htm 
 
 
Centers for Disease Control and Prevention [CDC]. (2017). Health Effects of Cigarette 
Smoking. Retrieved from 
https://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/effects_cig_s
moking/index.htm 
 
 
 
	 28	
Chung, K. C., Kowalski, C. P., Kim, H. M., & Buchman, S. R. (2000). Maternal cigarette 
smoking during pregnancy and the risk of having a child with cleft lip/palate. Palstic 
and Reconstructive Surgery, 105(2), 485–91. Retrieved from 
https://www.ncbi.nlm.nih.gov/pubmed/10697150 
 
 
Curtin, S. C., & Mathews, T. J. (2016). National Vital Statistics Reports Smoking 
Prevalence and Cessation Before and During Pregnancy: Data From the Birth 
Certificate, 2014. National Vital Statistics Reports, 65(1), 1–14. Retrieved from 
https://www.cdc.gov/nchs/data/nvsr/nvsr65/nvsr65_01.pdf 
 
 
Fifer, W. P., Fingers, S. T., Youngman, M., Gomez-Gribben, E., & Myers, M. M. (2009). 
Effects of Alcohol and Smoking During Pregnancy on Infant Autonomic Control. 
Dev Psychobiol, 51(3), 234–242. doi:10.1002/dev.20366.Effects 
 
 
Gallinat, J., Lang, U. E., Jacobsen, L. K., Bajboug, M., Kalus, P., von Haebler, D., … 
Schubert, F. (2007). Abnormal hippocampal neurochemistry in smokers: evidence 
from proton magnetic resonance spectroscopy at 3 T. Journal of Clinical 
Psychopharmacology, 27(1), 80–4. doi:10.1097/JCP.0b013e31802dffde 
 
 
Gong, Z., Xia, S., Liu, L., Feng, C., & Guo, A. (1998). Operant visual learning and 
memory in Drosophila mutants dunce, amnesiac and radish. Journal of Insect 
Physiology, 44(12), 149–1158. 
 
 
Hofhuis, W. (2003). Adverse health effects of prenatal and postnatal tobacco smoke 
exposure on children. Archives of Disease in Childhood, 88(12), 1086–1090. 
doi:10.1136/adc.88.12.1086 
 
 
Honein, M. A., Rasmussen, S. A., Reefhuis, J., Romitti, P. A., Lammer, E. J., Sun, L., … 
Correa, A. (2017). Clefts Linked references are available on JSTOR for this article : 
Maternal Smoking and Environmental Tobacco Smoke Exposure and the Risk of 
Orofacial Clefts, 18(2), 226–233. doi:10.1097/01.ede.0000254430.61294.cO 
 
 
Kaun, K. R., Devineni, A. V., & Heberlein, U. (2012). Drosophila melanogaster as a 
model to study drug addiction. Human Genetics, 131, 959–975. 
doi:10.1007/s00439-012-1146-6 
 
 
Kihara, T., & Shimohama, S. (2004). Alzheimer ’ s disease and acetylcholine receptors. 
Acta Neurobiologiae Experimentalis, 64, 99–105. 
 
 
 
 
 
	 29	
Langley, K., Heron, J., Smith, G. D., & Thapar, A. (2011). Maternal and paternal 
smoking during pregnancy and risk of ADHD symptoms in offspring: Testing for 
intrauterine effects. American Journal of Epidemiology, 176(3), 261–268. 
doi:10.1093/aje/kwr510 
 
 
Logan-Garbisch, T., Bortolazzo, A., Luu, P., Ford, A., Do, D., Khodabakhshi, P., & 
French, R. L. (2014). Developmental ethanol exposure leads to dysregulation of 
lipid metabolism and oxidative stress in Drosophila. G3 (Bethesda, Md.), 5(1), 49–
59. doi:10.1534/g3.114.015040 
 
 
Luu, P., Zaki, S. A., Tran, D. H., & French, R. L. (2016). A novel gene controlling the 
timing of courtship initiation in Drosophila melanogaster. Genetics, 202(3), 1043-
1053. 
 
 
Mcclernon, F. J., & Kollins, S. H. (2008). ADHD and Smoking. Annals of the New York 
Academy of Sciences, 1141, 131–147. doi:10.1196/annals.1441.016.ADHD 
 
 
McClure, K. D., French, R. L., & Heberlein, U. (2011). A Drosophila model for fetal 
alcohol syndrome disorders: role for the insulin pathway. Dis Model Mech, 4(3), 
335–346. doi:10.1242/dmm.006411 
 
McMurray, M. S., Williams, S. K., Jarrett, T. M., Cox, E. T., E.E., F., Overstreet, D. H., 
& Walker, C. H. (2008). Gestational ethanol and nicotine exposure: effects on 
maternal behavior, oxytocin, and offspring ethanol intake in the rat. Neurotoxicology 
and Teratology Journal, 30(6), 475–86. doi:10.1038/jid.2014.371 
 
 
Mishra, G. D., Dobson, A. J., & Schofield, M. J. (2000). Cigarette smoking, menstrual 
symptoms and miscarriage among young women. Australian and New Zealand 
Journal of Public Health, 24(4), 413–420. doi:10.1111/j.1467-842X.2000.tb01604.x 
 
 
National Institute of Mental Health. (2016). Attention Deficit Hyperactivity Disorder. 
Retrieved from https://www.nimh.nih.gov/health/topics/attention-deficit-
hyperactivity-disorder-adhd/index.shtml 
 
 
National Institute on Drug Abuse. (2017). What is Tobacco? Retrieved from 
https://www.drugabuse.gov/publications/drugfacts/cigarettes-other-tobacco-products 
 
 
Pereira, P. P. da S., Da Mata, F. A. F., Figueiredo, A. C. G., de Andrade, K. R. C., & 
Pereira, M. G. (2017). Maternal Active Smoking During Pregnancy and Low Birth 
Weight in the Americas: A Systematic Review and Meta-analysis. Nicotine & 
Tobacco Research, 19(5), 497–505. doi:10.1093/ntr/ntw228 
 
	 30	
Polańska, K., Jurewicz, J., & Hanke, W. (2015). Smoking and alcohol drinking during 
pregnancy as the risk factors for poor child neurodevelopment – A review of 
epidemiological studies. International Journal of Occupational Medicine and 
Environmental Health, 28(3), 419–443. doi:10.13075/ijomeh.1896.00424 
 
 
Regensburger, M., Prots, I., & Winner, B. (2014). Adult Hippocampal Neurogenesis in 
Parkinson ’ s Disease : Impact on Neuronal Survival and Plasticity, 2014. 
 
 
Riah, O., Courriere, P., Dousset, J. C., Todeschi, N., & Labat, C. (1998). Nicotine is more 
efficient than cotinine at passing the blood-brain barrier in rats. Cellular and 
Molecular Neurobiology, 18(3), 311–8. Retrieved from 
https://www.ncbi.nlm.nih.gov/pubmed/9590561 
 
 
Rosenthal, D. G., Weitzman, M., & Benowitz, N. L. (2011). Nicotine Addiction: 
Mechanisms and Consequences. International Journal of Mental Health, 40(1), 22–
38. doi:10.2753/IMH0020-7411400102 
 
 
Roy, T. S., Seidler, F. J., & Slotkin, T. a. (2002). Prenatal nicotine exposure evokes 
alterations of cell structure in hippocampus and somatosensory cortex. The Journal 
of Pharmacology and Experimental Therapeutics, 300(1), 124–133. 
doi:10.1124/jpet.300.1.124 
 
 
Secker-Walker, R. H., & Vacek, P. M. (2003). Relationships between cigarette smoking 
during pregnancy, gestational age, maternal weight gain, and infant birthweight. 
Addictive Behaviors, 28(1), 55–66. doi:10.1016/S0306-4603(01)00216-7 
 
 
Shah, T., Sullivan, K., & Carter, J. (2006). Sudden infant death syndrome and reported 
maternal smoking during pregnancy. American Journal of Public Health, 96(10), 
1757–1759. doi:10.2105/AJPH.2005.073213 
 
 
Shaw, P., Cirelli, C., Greenspan, R., & Tononi, G. (2000). Correlates of Sleep and 
Waking. Science, 287, 1834–1837. 
 
 
Tran, D. H., Meissner, G. W., French, R. L., & Baker, B. S. (2014). A small 
subset of fruitless subesophageal neurons modulate early courtship in 
Drosophila. PloS one, 9(4), e95472. 
 
 
Wisborg, K., Kesmodel, U., Henriksen, T. B., Olsen, S. F., & Secher, N. J. (2000). A 
prospective study of smoking during pregnancy and SIDS. Archives of Disease in 
Childhood, 83(3), 203–6. doi:10.1136/adc.83.3.203 
 
	 31	
Wolf, F. W., & Heberlein, U. (2003). Invertebrate models of drug abuse. Journal of 
Neurobiology, 54(1), 161–178. doi:10.1002/neu.10166 
 
 
Xiu, X., Puskar, N. L., Shananta, J. A. P., Lester, H., & Dougherty, D. (2009). Nicotine 
Binding to Brain Receptors Requires a Strong Cation-π Interaction. Nature, 
458(7237), 534–537. doi:10.1002/nbm.3369.Three 
 
